| abstract |
Disclosed is a therapeutic or prophylactic agent for allergic dermatitis. The therapeutic or prophylactic agent comprises a glycine derivative having a specific structure, such as a compound represented by the formula below (i.e., [(E)-2-(2,6-dichlorobenzamide)-5-[4-(isopropyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid]), or a pharmacologically acceptable salt thereof as an active ingredient. The therapeutic or prophylactic agent has a significant therapeutic or prophylactic effect. |